MD Anderson Cancer Center
@MDAndersonNewsMD Anderson is a global leader in cancer care, research, education and training, and prevention. Our mission: #EndCancer. Appointments available: 1-877-632-6789
Similar User
@theNCI
@DanaFarber
@MSKCancerCenter
@AACR
@OncLive
@Annals_Oncology
@CancerNetwrk
@DukeCancer
@ASCO
@JournalCancer
@ASCOPost
@OncJournal
@JCO_ASCO
@NCCN
@TheCancerLetter
With the goal of advancing cell therapies for patients like JC Cox, MD Anderson has launched the Institute for Cell Therapy Discovery & Innovation. Read more: brnw.ch/21wOup7 @lab_rezvani #EndCancer
The National Comprehensive Cancer Network has updated guidance on genetic testing for numerous cancers, including extending the age for genetic testing for #BreastCancer. Our Dr. Banu Arun shares insights on the revised guidelines: brnw.ch/21wODWK @NCCN #EndCancer
#HTAN2024: @IamLinghua and the GAME3D Team @MDAndersonNews are sharing the Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D) that is constructing a 3D precancer atlas to enable studies of #GastricCancer development. reporter.nih.gov/project-detail…
Honored to be invited to @FOX26Houston this morning during #LungCancerAwarenessMonth! The face of lung cancer has changed—anyone with lungs can be at risk. Let’s end the stigma & raise awareness together. @MDAndersonNews #EndCancer
Swollen lymph nodes, night sweats and weight loss can all be symptoms of lymphoma. Here, survivors share what symptoms led to their diagnoses: brnw.ch/21wOC3m #Lymphoma #EndCancer
Learn more about lung cancer symptoms, diagnosis and treatment options at MD Anderson: bit.ly/2HTQ2fZ #LungCancer #EndCancer
Huge shoutout to my amazing clinic team for setting up this impactful display for #LungCancerAwarenessMonth! 📢 ANYONE with lungs is at risk for lung cancer! #EndCancer @MDAndersonNews
Multiple approaches to @MDAndersonNews’s strategy in global cancer control efforts. @kmschmeler discusses ongoing program in Zambia. #endcancer #radonc @LilieLinMD
Our Dr. Jason Westin is a candidate for @ASCO's Board of Directors. Voting is open now until Dec. 3: bit.ly/4fpBYJf #EndCancer
I’m honored to be on the ballot for the ASCO Board of Directors with all the other amazing candidates. Learn more and 🗳️ ⬇️
Weight-loss injection drugs, called GLP-1 agonists, have shown that patients can lose up to 20% of their body weight. But they aren't for everyone. What we know about how their impact cancer risk and what patients should know: brnw.ch/21wOyn2 #EndCancer
On this #VeteransDay, we at @MDAndersonNews honor the veterans and active service members who have served our nation with courage, sacrifice and unwavering dedication. Thank you for your service. #EndCancer
Congratulations to everyone who contributed to MD Anderson’s 98 abstracts on display at #SITC24 this past weekend, which highlighted the synergies between our discovery and translational science. @SITCancer #EndCancer
“Spatial omics is an incredibly exciting field that’s evolving quickly,” our Dr. Linghua Wang shared at #SITC24. “Working closely with pathologists is especially important and can lead to unique insights.” Learn more about her work as an associate member of the James P. Allison…
The latest research from MD Anderson has been presented at #SITC24 and provides new insights into the tumor microenvironment and showcases immunotherapy advances across a variety of cancer types. Learn more: mdanderson.org/newsroom/md-an… #EndCancer
In an education session at #SITC24, our Dr. Jason Westin shared insights on future directions of CAR T cells compared to T cell engaging bispecifics. “CAR T cells and bispecifics are changing the paradigms for how we treat our patients,” @Lymphoma_Doc says. @SITCancer #EndCancer
Targeting Ednrb in a unique population of iron-rich tumor associated macrophages in solid tumors represents a novel immunotherapeutic approach, our Dr. @IanFolkert shared at #SITC24. Learn more (Abstract 900): jitc.bmj.com/content/12/Sup… @SITCancer #EndCancer
Research led by Spencer Lea, a graduate student in the @DrCurran Laboratory investigated ways to leverage innate immune sensors to generate durable anti-glioma adaptive immune responses. Learn more (Abstract 1018): jitc.bmj.com/content/12/Sup… @SITCancer #SITC24 #EndCancer
United States Trends
- 1. $MAYO 9.936 posts
- 2. Tyson 388 B posts
- 3. Pence 44,1 B posts
- 4. Laken Riley 39,5 B posts
- 5. Dora 22,3 B posts
- 6. Ticketmaster 16,6 B posts
- 7. Kash 72 B posts
- 8. Mike Rogers 8.415 posts
- 9. #LetsBONK 5.993 posts
- 10. Cenk 10,8 B posts
- 11. Pirates 18,8 B posts
- 12. #FursuitFriday 15,5 B posts
- 13. Debbie 15,8 B posts
- 14. Mr. Mayonnaise 1.376 posts
- 15. Iron Mike 16,1 B posts
- 16. The UK 436 B posts
- 17. Gabrielle Union N/A
- 18. Scholars 10,7 B posts
- 19. Oscars 13,9 B posts
- 20. Al Gore 3.306 posts
Who to follow
-
National Cancer Institute
@theNCI -
Dana-Farber
@DanaFarber -
Memorial Sloan Kettering Cancer Center
@MSKCancerCenter -
AACR
@AACR -
OncLive.com
@OncLive -
Annals of Oncology
@Annals_Oncology -
CancerNetwork®
@CancerNetwrk -
Duke Cancer
@DukeCancer -
ASCO
@ASCO -
ACS Journal Cancer
@JournalCancer -
The ASCO Post
@ASCOPost -
The Oncologist
@OncJournal -
Journal of Clinical Oncology
@JCO_ASCO -
National Comprehensive Cancer Network (NCCN)
@NCCN -
The Cancer Letter
@TheCancerLetter
Something went wrong.
Something went wrong.